Sustainability of small-molecule API manufacturing ensures continued success. Improving the sustainability of small-molecule API manufacturing is essential to ensuring the continued success of the ...
The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...
In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...
As 2026 approaches, rising complexity, geopolitical pressures and new modalities are reshaping strategy, capacity and CDMO ...
−CDMO with a Six Decades-Long Reputation for Quality and Service Doubles Its Capacity to Take on New Development Projects− MORTON GROVE, Ill.--(BUSINESS WIRE)--Regis Technologies, Inc. today announced ...
The means for achieving therapeutic goals resides in the active pharmaceutical ingredient of the drug used, and therefore there must be a manufacturing process capable of producing this valuable ...
The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...
Poor API quality may often lead to delays in production and a shortage of supply. The API is, one might say, the most important element in a pharmaceutical product. Poor-quality APIs that do not meet ...
Syngene had successfully demonstrated the small-scale synthesis of a novel vascular calcification inhibitor API from lab-scale to tox-batch manufacturing. This was following the request of a pharma ...
BEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback